Y, W., Y, A., Y, H., K, K., R, I., & T, I. (2018). Factors impacting the efficacy of venlafaxine extended release 75–225 mg/day in patients with major depressive disorder: Exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study in Japan. Dove Medical Press.
Style de citation Chicago (17e éd.)Y, Watanabe, Asami Y, Hirano Y, Kuribayashi K, Itamura R, et Imaeda T. Factors Impacting the Efficacy of Venlafaxine Extended Release 75–225 Mg/day in Patients with Major Depressive Disorder: Exploratory Post Hoc Subgroup Analyses of a Randomized, Double-blind, Placebo-controlled Study in Japan. Dove Medical Press, 2018.
Style de citation MLA (8e éd.)Y, Watanabe, et al. Factors Impacting the Efficacy of Venlafaxine Extended Release 75–225 Mg/day in Patients with Major Depressive Disorder: Exploratory Post Hoc Subgroup Analyses of a Randomized, Double-blind, Placebo-controlled Study in Japan. Dove Medical Press, 2018.